| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |